# Title Funder Funding Start End Status
21 Multi-protein assembly of intracellular ion-sensitive potassium channel complexes BBSRC
£465,868
April 30, 2006 April 29, 2009 Closed
22 Single neuron computation MRC
£3,429,092
Nov. 1, 2002 Dec. 31, 2009 Closed
23 Regulation of glutamate transporter EAAT2 activity lateral diffusion and membrane trafficking by palmitoylation and interacting proteins BBSRC
£1,119,190
Sept. 30, 2011 March 30, 2015 Closed
24 The impact of metformin exposure on placental ageing, metabolism, and mitochondrial function MRC
£1,177,844
Sept. 29, 2020 Sept. 28, 2023 Active
25 The impact of metformin exposure on placental ageing, metabolism, and mitochondrial function MRC
£3,040,010
Sept. 29, 2020 Sept. 29, 2024 Active
26 Intrinsic plasticity of neuronal excitability in the auditory brainstem and neocortex: nitrergic signalling to voltage-gated potassium channels MRC
£1,384,778
Feb. 4, 2013 July 30, 2016 Closed
27 A randomised placebo-controlled trial of immunotherapy in patients with psychosis associated with anti-neuronal membrane antibodies (SINAPPS 2) MRC
£4,939,666
July 31, 2016 March 31, 2024 Active
28 Control of uterine Ca by membrane potential: role of the T-type calcium channels. BBSRC
£658,546
Dec. 1, 2006 Nov. 30, 2009 Closed
29 Control of uterine Ca by membrane potential: role of the T-type calcium channels. BBSRC
£1,646,365
Dec. 1, 2006 Nov. 30, 2009 Closed
30 The role of P21/Cdc42/Rac1-activated kinases (PAK) in prostate cancer. MRC
£370,800
Sept. 29, 2012 Sept. 28, 2015 Closed
31 The role of P21/Cdc42/Rac1-activated kinases (PAK) in prostate cancer. MRC
£927,000
Sept. 29, 2012 Sept. 29, 2015 Closed
32 Integration of calcium signalling mechanisms in neural modelling BBSRC
£514,446
March 1, 2011 Feb. 28, 2014 Closed
33 Brain-enriched voltage-gated calcium channel isoforms: novel, genetically informed, therapeutic targets for psychiatric disorders MRC
£901,792
May 31, 2017 Nov. 30, 2019 Closed
34 Molecular mechanisms of voltage-gated potassium channel clustering in myelinated axons BBSRC
£1,173,476
March 31, 2020 March 30, 2023 Active
35 REVing-down: targeting the circadian clock in metabolic disease MRC
£1,159,254
Feb. 1, 2017 May 28, 2020 Closed
36 Regulation of synaptic inhibition by GABAA receptor trafficking under normal conditions and in neurological and neuropsy MRC
£3,867,586
Sept. 30, 2009 Jan. 31, 2015 Closed
37 Elucidating early stage ALS pathomecanisms that drive mitochondrial dysfunction MRC
£1,701,162
Jan. 1, 2020 May 6, 2023 Active
38 Elucidating early stage ALS pathomecanisms that drive mitochondrial dysfunction MRC
£4,252,905
Jan. 1, 2020 May 7, 2023 Closed
39 Developing an evolutionary model for metabolic syndrome: understanding energy sparing adaptations in geothermal populations of stickleback BBSRC
£3,872,665
March 14, 2022 March 13, 2026 Active
40 Unveiling novel functions of peroxisomal lipid-binding proteins in interorganellar cooperation and regulation of lipid metabolism BBSRC
£845,412
Sept. 30, 2016 Dec. 3, 2019 Closed
Reset